Spots Global Cancer Trial Database for rad001 (everolimus, afinitor®)
Every month we try and update this database with for rad001 (everolimus, afinitor®) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Safety and Tolerability Profile of RAD001 Daily in Chinese Patients With Advanced Pulmonary Neuroendocrine Tumor | NCT01175096 | Neuroendocrine ... Carcinoid Tumor | RAD001 (everoli... | 18 Years - | Guangdong Provincial People's Hospital | |
Safety and Tolerability Profile of RAD001 Daily in Chinese Patients With Advanced Pulmonary Neuroendocrine Tumor | NCT01175096 | Neuroendocrine ... Carcinoid Tumor | RAD001 (everoli... | 18 Years - | Guangdong Provincial People's Hospital |